Oral fluoropyrimidines in the treatment of colorectal cancer

By Meropol N.J.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1509-1513

Elsevier

Access to resources Recommend Favorite

Oral Fluoropyrimidines in the Treatment of Advanced Colorectal Cancer: Results of Two Consecutive Phase II Trials

By Adimi Parvin   Hansen Flemming   Kjaer Mogens   Aabo Kristian   Keldsen Nina   Pfeiffer Per   Sandberg Erik   Jakobsen Anders  

Acta Oncologica, Vol. 41, Iss. 2, 2002-04 ,pp. : 202-203

Informa Healthcare

Access to resources Recommend Favorite

Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer

By Tsuji Takashi   Sawai Terumitsu   Takeshita Hiroaki   Nakagoe Tohru   Hidaka Shigekazu   Yamaguchi Hiroyuki   Yasutake Toru   Nagayasu Takeshi   Tagawa Yutaka  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 531-536

Springer Publishing Company

Access to resources Recommend Favorite

Cost-Effective Strategies in the Management of Advanced Colorectal Cancer

By Scott L.C.   Twelves C.  

American Journal of Cancer, Vol. 2, Iss. 2, 2003-01 ,pp. : 111-124

Adis International

Access to resources Recommend Favorite

A perspective on the current management of advanced colorectal cancer

By Casagrande Mariaelena   Cremolini Chiara   Loupakis Fotios   Aprile Giuseppe  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1687-1691

Future Medicine

Access to resources Recommend Favorite